Compared to adult, pediatric AML tends to exhibit higher mutation frequencies in MYC ITD and WT1, and less frequent mutations in DNMT3A and TP53. Meanwhile, studies in adult solid tumors have also shown that different ethnic backgrounds may have a profound impact on molecular drivers of disease development and progression17,18. The gene discussed is WT1; the disease is acute myeloid leukemia.